Liver Carcinoma Clinical Trial
Official title:
The Illness of Uncertainty, Personality and Coping Strategies in Patients With Hepatocellular Carcinoma
The aims of this study are to (1) understand the uncertainty , personality and coping strategies in patients with HCC, and identify the significant factors for coping.
A cross-sectional correlated design will be used and (2) patients will be recruited by purposive sampling from wards and outpatient departments at a medical center in Taipei. ;
Observational Model: Case-Only, Time Perspective: Cross-Sectional
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01020812 -
Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04443322 -
Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 )
|
N/A | |
| Completed |
NCT02305459 -
CIRSE Registry for SIR-Spheres Therapy
|
||
| Terminated |
NCT00791544 -
Dose Finding Study of AVE1642 in Patients With Advanced or Metastatic Liver Carcinoma
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04682847 -
Radiotherapy With Iron Oxide Nanoparticles (SPION) on MR-Linac for Primary & Metastatic Hepatic Cancers
|
||
| Completed |
NCT02424955 -
Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation
|
N/A | |
| Completed |
NCT03775863 -
AFP Model and Liver Transplantation.
|
||
| Not yet recruiting |
NCT04825470 -
Liver Transplantation for Unresectable GIST Liver Metastases
|
N/A | |
| Recruiting |
NCT06144385 -
A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma
|
Phase 1 | |
| Completed |
NCT01717729 -
Hepatocellular Carcinoma Treated With Iodine-125 Implantation
|
Phase 3 | |
| Completed |
NCT03178409 -
Combined HCC-MFCCC
|
N/A | |
| Suspended |
NCT04955808 -
Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery
|
||
| Withdrawn |
NCT01744639 -
Analysis of Body Composition in Patients With Hepatocellular Carcinoma in Radioablation
|
N/A | |
| Completed |
NCT01482442 -
SorAfenib Versus RADIOEMBOLIZATION in Advanced Hepatocellular Carcinoma
|
Phase 3 | |
| Active, not recruiting |
NCT01272557 -
Sorafenib Plus Doxorubicin Versus Sorafenib Alone for the Treatment of Advanced Hepatocellular Carcinoma: a Randomized Phase II Trial
|
Phase 2 | |
| Completed |
NCT00328770 -
De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma
|
Phase 2/Phase 3 | |
| Completed |
NCT05681234 -
Clinical Application of 18F-labeled RD2 PET/CT Imaging in the Diagnosis and Treatment of Small Liver Carcinoma
|
N/A | |
| Terminated |
NCT00767234 -
Permission to Collect Blood Over Time for Research
|
N/A | |
| Active, not recruiting |
NCT02465060 -
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
|
Phase 2 | |
| Recruiting |
NCT04288323 -
Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis
|
Phase 4 |